BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9816237)

  • 1. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN; Sgagias MK
    Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K; Keski-Oja J
    Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
    Arrick BA; Korc M; Derynck R
    Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
    Pang XP; Yoshimura M; Wang J; Dubinett SM
    Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
    Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
    Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
    Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
    J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
    J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
    Nakagawa T; Yamaguchi M
    J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
    McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
    Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo growth regulation by cytokine in breast cancer cells showing an estradiol-inhibitive response in vitro.
    Matsuoka H; Tomisaki S; Ohno S; Ikejiri K; Saku M; Shirasaka C; Ueo H; Sugimachi K
    Anticancer Res; 1997; 17(4A):2549-54. PubMed ID: 9252679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
    Davidson NE; Prestigiacomo LJ; Hahm HA
    Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha.
    Guerrero J; Tobar N; Cáceres M; Espinoza L; Escobar P; Dotor J; Smith PC; Martínez J
    Breast Cancer Res Treat; 2010 Jan; 119(2):497-508. PubMed ID: 19649705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin.
    Chorna I; Fedorenko O; Datsyuk L; Stoika R
    Exp Oncol; 2005 Jun; 27(2):156-8. PubMed ID: 15995636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones.
    Pagliacci MC; Fumi G; Migliorati G; Grignani F; Riccardi C; Nicoletti I
    Lymphokine Cytokine Res; 1993 Dec; 12(6):439-47. PubMed ID: 8123760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.